{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:30:09Z","timestamp":1790141409213,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.autrev.2011.12.005","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T17:12:35Z","timestamp":1324055555000},"page":"699-704","source":"Crossref","is-referenced-by-count":122,"title":["Cytokines and Behcet's Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Z.Y.","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.12.005_bb0295","first-page":"S53","article-title":"The lumps and bumps of Beh\u00e7et's syndrome","volume":"3","author":"Yazici","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.12.005_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cyto.2010.11.001","article-title":"Mechanism of regulation of autoimmunity by iNKT cells","volume":"53","author":"Novak","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2011.12.005_bb0300","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Beh\u00e7et's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.12.005_bb0020","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1186\/ar1798","article-title":"Identification of kinectin as a novel Beh\u00e7et's disease autoantigen","volume":"7","author":"Lu","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.12.005_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/pr.109.002006","article-title":"Therapeutic targeting of B cells for rheumatic autoimmune diseases","volume":"63","author":"Engel","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.autrev.2011.12.005_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.autrev.2006.08.008","article-title":"Increased proportion of CD3+CD4\u2212CD8\u2212 double-negative T cells in peripheral blood of children with Behcet's disease","volume":"6","author":"Ling","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.12.005_bb0035","first-page":"1428","article-title":"Production of TNF-alpha and IL-1 in active Beh\u00e7et's disease","volume":"17","author":"Hamzaoui","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00296-005-0040-0","article-title":"Synovial proinflammatory cytokines and their correlation with matrixmetalloproteinase-3 expression in Behc\u00b8et's disease. Does interleukin-1b play a major role in Beh\u00e7et's synovitis?","volume":"27","author":"Pay","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.12.005_bb0305","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","article-title":"Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease","volume":"42","author":"Karasneh","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2011.12.005_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00403-007-0794-1","article-title":"Relationship between periodontal findings and specific polymorphisms of interleukin-1 and -1 in Turkish patients with Beh\u00e7et's disease","volume":"300","author":"Akman","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2011.12.005_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.0906-6705.2005.00253.x","article-title":"Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease","volume":"14","author":"Coskun","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-149-4-200808190-00018","article-title":"Resistant Beh\u00e7et disease responsive to anakinra","volume":"19","author":"Botsios","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2011.12.005_bb0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arcmed.2010.02.002","article-title":"TNF polymorphisms in patients with Beh\u00e7et disease: a meta-analysis","volume":"41","author":"Touma","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.autrev.2011.12.005_bb0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.autrev.2010.10.002","article-title":"Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation","volume":"10","author":"Commodaro","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.12.005_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","article-title":"Effect of infliximab in progressive neuro-Beh\u00e7et's syndrome","volume":"272","author":"Kikuchi","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2011.12.005_bb0080","unstructured":"Midori Misumi, Eri Hagiwara, Mitsuhiro Takeno, et al. Cytokine production profile in patients with Behcet's disease treated with infliximab; 24 (2003) pp. 210\u2013218."},{"key":"10.1016\/j.autrev.2011.12.005_bb0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease","volume":"33","author":"Akdeniz","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.autrev.2011.12.005_bb0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","article-title":"Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Beh\u00e7et's disease","volume":"18","author":"Adam","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0315","first-page":"551","article-title":"Cytokine profile in Beh\u00e7et uveitis","volume":"109","author":"Nalbant","year":"2008","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.autrev.2011.12.005_bb0100","first-page":"599","article-title":"Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Beh\u00e7et's syndrome","volume":"10","author":"Wang","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","article-title":"Interleukin-6 in neuro-Beh\u00e7et's disease: association with disease subsets and long-term outcome","volume":"44","author":"Akman-Demir","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2011.12.005_bb0110","first-page":"1147","article-title":"Nervous system involvement in Beh\u00e7et's disease","volume":"41","author":"Central","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.autrev.2011.12.005_bb0320","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mehy.2008.01.011","article-title":"Tocilizumab may be a potential addition to our weapons against neuro-Beh\u00e7et's disease","volume":"71","author":"Borhani Haghighi","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2011.12.005_bb0120","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1093\/nar\/17.17.6855","article-title":"Rapid detection and sequencing of alleles in the 3\u2032 flanking region of the interleukin-6 gene","volume":"17","author":"Bowcock","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.autrev.2011.12.005_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/ard.2004.024208","article-title":"Association between interleukin 6 gene polymorphisms and Behcet's disease in Korean people","volume":"64","author":"Chang","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.12.005_bb0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0181-5512(06)73762-7","article-title":"Production of Th1\/Th2 cytokines and nitric oxide in Beh\u00e7et's uveitis and idiopathic uveitis","volume":"29","author":"Guenane","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0181-5512(08)71433-5","article-title":"Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Beh\u00e7et and idiopathic uveitis","volume":"31","author":"Belguendouz","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Beh\u00e7et uveitis","volume":"142","author":"Ahn","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10067-006-0503-z","article-title":"T helper 1 type cytokines polymorphisms: association with susceptibility to Beh\u00e7et's disease","volume":"26","author":"Alayli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2011.12.005_bb0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2011.12.005_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","article-title":"Etiopathogenesis of Behcet's disease","volume":"9","author":"Mendoza-Pinto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.12.005_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","article-title":"Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease","volume":"30","author":"Oztas","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00296-005-0029-8","article-title":"Serum interleukin-18 levels in patients with Beh\u00e7et's disease. Is its expression associated with disease activity or clinical presentations?","volume":"26","author":"Musabak","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.12.005_bb0175","first-page":"S59","article-title":"Interleukin-18 gene polymorphisms in Korean patients with Beh\u00e7et's disease","volume":"23","author":"Jang","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0180","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.humimm.2006.07.012","article-title":"Interleukin-18 promoter polymorphisms in patients with Beh\u00e7et's disease","volume":"67","author":"Lee","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0325","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et's disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.12.005_bb0330","article-title":"Interferon-\u03b3 and nitric oxide production during Beh\u00e7et uveitis: immunomodulatory effect of interleukin-10","volume":"21","author":"Belguendouz","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2011.12.005_bb0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humimm.2006.11.010","article-title":"IL-10 genotype analysis in patients with Beh\u00e7et's disease","volume":"68","author":"Wallace","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0200","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s11033-010-0015-4","article-title":"Analyses of functional IL10 and TNF-\u03b1 genotypes in Beh\u00e7et's syndrome","volume":"37","author":"Ate\u015f","year":"2010","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2011.12.005_bb0205","doi-asserted-by":"crossref","unstructured":"Nicolas Manel. In vitro differentiation of human Th-17 CD4+ T cells. Protocol Exchange. 2008 published online.","DOI":"10.1038\/nprot.2008.122"},{"key":"10.1016\/j.autrev.2011.12.005_bb0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et's disease patients, relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0215","first-page":"880","article-title":"Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A","volume":"19","author":"Chi","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.autrev.2011.12.005_bb0220","first-page":"6","article-title":"CD4+ T cells from Behcet patients produce high levels of IL-17","volume":"26","author":"Chi","year":"2011","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.autrev.2011.12.005_bb0225","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2009.119420","article-title":"IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population","volume":"69","author":"Jiang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.12.005_bb0335","doi-asserted-by":"crossref","first-page":"CR227","DOI":"10.12659\/MSM.881720","article-title":"Expression of Th-17 and ROR\u03b3t mRNA in Beh\u00e7et's Disease","volume":"17","author":"Hamzaoui","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2011.12.005_bb0235","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1167\/iovs.10-5286","article-title":"Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Beh\u00e7et's patients with uveitis: a new activity marker?","volume":"51","author":"Usui","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2011.12.005_bb0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00296-008-0664-y","article-title":"Interleukin-17F gene polymorphisms in Korean patients with Beh\u00e7et's disease","volume":"29","author":"Jang","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.12.005_bb0340","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-4632.2004.02184.x","article-title":"Serum interleukin-8 as a serologic marker of activity in Beh\u00e7et's disease","volume":"44","author":"G\u00fcr-Toy","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","article-title":"Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement","volume":"48","author":"Durmazlar","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0345","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1399-0039.2006.00736.x","article-title":"Haplotype association of IL-8 gene with Behcet's disease","volume":"69","author":"Lee","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.12.005_bb0260","first-page":"93","article-title":"Polymorphisms of the IL-8 and CXCR2 genes are not associated with Beh\u00e7et's disease","volume":"32","author":"Duymaz-Tozkir","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0265","first-page":"S103","article-title":"IL-6 receptor, IL-8 receptor and TNF-alpha238 (G\/A) polymorphisms are not associated with Beh\u00e7et's disease in patients of German or Turkish origin","volume":"26","author":"Storz","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et's disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0350","first-page":"129","article-title":"Enhanced production of macrophage inhibitory protein-1alpha in patients with Beh\u00e7et's disease","volume":"34","author":"Kim","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-0039.2004.00150.x","article-title":"Chemokine gene polymorphisms associate with gender in patients with uveitis","volume":"63","author":"Chen","year":"2004","journal-title":"Tissue"},{"key":"10.1016\/j.autrev.2011.12.005_bb0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2011.01.014","article-title":"Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"139","author":"El-Asrar","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2011.12.005_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.autrev.2010.08.013","article-title":"Regulatory T cells: the suppressor arm of the immune system","volume":"10","author":"Langier","year":"2010","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211003065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211003065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T23:37:38Z","timestamp":1713224258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211003065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1568997211003065"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.12.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}